BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9433394)

  • 1. Immunosuppressant pharmacodynamics on lymphocytes from healthy subjects and patients with chronic renal failure, nephrosis, and psoriasis: possible implications for individual therapeutic efficacy.
    Hirano T; Oka K; Takeuchi H; Kozaki K; Matsuno N; Nagao T; Kozaki M; Ichikawa M; Yoshida M; Umezawa Y; Hirata M; Oh-i T; Koga M
    Clin Pharmacol Ther; 1997 Dec; 62(6):652-64. PubMed ID: 9433394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial superantigen TSST-1 attenuates suppressive efficacy of glucocorticoids and calcineurin inhibitors against blastogenesis of peripheral blood mononuclear cells from patients with antineutrophil cytoplasmic antibody-associated vasculitis and nephrosis.
    Hirano T; Fukushima H; Sasaki Y; Yoshikawa N; Yoshida M; Oka K
    Int Immunopharmacol; 2006 Jun; 6(6):924-34. PubMed ID: 16644478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual pharmacodynamics assessed by antilymphocyte action predicts clinical cyclosporine efficacy in psoriasis.
    Hirano T; Oka K; Umezawa Y; Hirata M; Oh-i T; Koga M
    Clin Pharmacol Ther; 1998 Apr; 63(4):465-70. PubMed ID: 9585801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial superantigen TSST-1 attenuates suppressive efficacy of glucocorticoids and calcineurin inhibitors against blastogenesis of peripheral blood mononuclear cells from patients with chronic renal failure on hemodialysis treatment.
    Konno O; Hirano T; Katsuyama K; Oka K; Matsuno N; Nagao T
    Transpl Immunol; 2007 Apr; 17(3):187-92. PubMed ID: 17331845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressive potencies of calcineurin inhibitors against the mitogen-induced blastogenesis of peripheral-blood mononuclear cells of myasthenia gravis patients.
    Tanaka S; Nakajima K; Hirano T; Oka K; Saito T; Wakata N
    J Pharm Pharmacol; 2008 Oct; 60(10):1341-6. PubMed ID: 18812027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of cyclosporine cellular pharmacodynamics in minimal change nephrotic syndrome.
    Hirano T; Akashi T; Keira T; Oka K; Ihoya N; Yoshida M
    Clin Pharmacol Ther; 2000 Nov; 68(5):532-40. PubMed ID: 11103756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine pharmacological efficacy estimated by lymphocyte immunosuppressant sensitivity test before and after renal transplantation.
    Sugiyama K; Isogai K; Toyama A; Satoh H; Saito K; Nakagawa Y; Tasaki M; Takahashi K; Saito N; Hirano T
    J Clin Pharm Ther; 2009 Oct; 34(5):539-45. PubMed ID: 19744009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of cholesterol in cyclosporine pharmacodynamics in minimal change nephrotic syndrome.
    Hirano T; Kawamura T; Fukuda S; Kohsaka S; Yoshikawa N; Yoshida M; Oka K
    Clin Pharmacol Ther; 2003 Dec; 74(6):581-90. PubMed ID: 14663460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of the effects of betamethasone butyrate propionate, vitamin D3 derivatives, and cyclosporine on human lymphocyte-proliferation stimulated with a hemolytic streptococci-derived superantigen.
    Arai K; Uchiyama T; Okubo Y; Tsuboi R; Oka K; Hirano T
    Eur J Pharmacol; 2007 Oct; 571(2-3):222-30. PubMed ID: 17628528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of dialysis patients' lymphocyte IL-2R expression by glucocorticoids and cyclosporine.
    Briggs WA; Gao ZH; Xing JJ; Scheel PJ; Gimenez LF; Samaniego MD; Choi MJ; Burdick JF
    Cytokine; 1997 Aug; 9(8):624-8. PubMed ID: 9245491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients.
    Herman M; Weinstein T; Korzets A; Chagnac A; Ori Y; Zevin D; Malachi T; Gafter U
    J Lab Clin Med; 2001 Jan; 137(1):14-20. PubMed ID: 11150019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of peripheral blood lymphocyte sensitivity to glucocorticoids for the differentiation of high-risk patients with decreased allograft function after glucocorticoid withdrawal in renal transplantation.
    Muhetaer G; Takeuchi H; Unezaki S; Kawachi S; Iwamoto H; Nakamura Y; Shimazu M; Sugiyama K; Hirano T
    Clin Ther; 2014 Aug; 36(8):1264-72. PubMed ID: 25037282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte-sensitivity to glucocorticoid correlates with the sensitivity to cyclosporin A and tacrolimus in chronic renal failure patients.
    Horigome A; Hirano T; Oka K; Takeuchi H; Sakurai E; Kozaki K; Matsuno N; Nagao T; Kozaki M
    Br J Clin Pharmacol; 1999 Oct; 48(4):573-8. PubMed ID: 10583028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of mRNA expression of transcription factors in glucocorticoid sensitivity of peripheral blood mononuclear cells and disease state in rheumatoid arthritis.
    Onda K; Rimbara E; Hirano T; Oka K; Abe H; Tahara K; Takanashi H; Tsuboi N; Niitsuma T; Hayashi T
    J Rheumatol; 2004 Mar; 31(3):464-9. PubMed ID: 14994389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between plasma leptin or soluble cleaved leptin-receptor concentrations and glucocorticoid sensitivity of peripheral blood mononuclear cells in patients with nephrotic syndrome.
    Henmi K; Yoshida M; Yoshikawa N; Nakabayashi I; Hirano T
    Int Immunopharmacol; 2008 Dec; 8(12):1703-6. PubMed ID: 18700169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased sensitivities of peripheral blood mononuclear cells to immunosuppressive drugs in cirrhosis patients awaiting liver transplantation.
    Mijiti A; Matsuno N; Iwahori T; Takeuchi H; Nagao T; Oka K; Hirano T
    Cell Transplant; 2006; 15(10):885-91. PubMed ID: 17299993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of glucocorticoid pharmacodynamics assessed by antilymphocyte action in kidney transplantation. Marked difference between prednisolone and methylprednisolone.
    Hirano T; Oka K; Takeuchi H; Sakurai E; Matsuno N; Tamaki T; Kozaki M
    Transplantation; 1994 May; 57(9):1341-8. PubMed ID: 8184473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of immunosuppressive drugs on platelet aggregation and soluble P-selectin levels in renal transplant patients.
    Sahin G; Akay OM; Kus E; Bal C; Yalcin AU; Gulbas Z
    Ren Fail; 2009; 31(2):111-7. PubMed ID: 19212907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential glucocorticoid responsiveness of hemodialysis patients' lymphocytes.
    Briggs WA; Gao ZH; Xing JJ; Scheel PJ; Burdick JF
    ASAIO J; 1997; 43(1):31-4. PubMed ID: 9116350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.